NASDAQ:EKSO Ekso Bionics Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Ekso Bionics Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $5.07 -0.23 (-4.34 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$5.06Now: $5.07▼$5.4350-Day Range$4.37MA: $5.52▼$7.3652-Week Range$2.25Now: $5.07▼$11.78Volume77,638 shsAverage Volume1.14 million shsMarket Capitalization$41.93 millionP/E RatioN/ADividend YieldN/ABeta2.09 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in North America, Europe, the Middle East, and Africa. The company operates through EksoHealth and EksoWorks segments. It primarily offers Ekso GT, a bionic suit that provides the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke. The company's Ekso device is primarily used in a hospital and rehabilitation setting. The company has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingEkso Bionics has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $9.67, Ekso Bionics has a forecasted upside of 90.7% from its current price of $5.07.Amount of Analyst CoverageEkso Bionics has only been the subject of 2 research reports in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesEkso Bionics has received 304 “outperform” votes. (Add your “outperform” vote.)Underperform VotesEkso Bionics has received 252 “underperform” votes. (Add your “underperform” vote.)Community SentimentEkso Bionics has received 54.68% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Ekso Bionics and other stocks. Vote “Outperform” if you believe EKSO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EKSO will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldEkso Bionics does not currently pay a dividend.Dividend GrowthEkso Bionics does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Ekso Bionics insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 24.30% of the stock of Ekso Bionics is held by insiders.Percentage Held by InstitutionsOnly 13.64% of the stock of Ekso Bionics is held by institutions. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Ekso Bionics are expected to decrease in the coming year, from ($0.65) to ($1.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Ekso Bionics is -1.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Ekso Bionics is -1.74, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEkso Bionics has a P/B Ratio of 4.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.24 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry General industrial machinery, Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:EKSO Previous SymbolOTCMKTS:EKSOD CUSIPN/A CIK1549084 Webwww.eksobionics.com Phone510-984-1761Debt Debt-to-Equity Ratio0.11 Current Ratio2.79 Quick Ratio2.46Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$13.92 million Price / Sales3.01 Cash FlowN/A Price / Cash FlowN/A Book Value$1.17 per share Price / Book4.33Profitability EPS (Most Recent Fiscal Year)($3.45) Net Income$-12,130,000.00 Net Margins-156.16% Return on Equity-275.25% Return on Assets-62.20%Miscellaneous Employees77 Outstanding Shares8,271,000Market Cap$41.93 million Next Earnings Date11/4/2020 (Estimated) OptionableNot Optionable $5.07 -0.23 (-4.34 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive EKSO News and Ratings via Email Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter. Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions How has Ekso Bionics' stock been impacted by Coronavirus (COVID-19)? Ekso Bionics' stock was trading at $0.2616 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EKSO shares have increased by 1,838.1% and is now trading at $5.07. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Ekso Bionics? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ekso Bionics. When is Ekso Bionics' next earnings date? Ekso Bionics is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020. View our earnings forecast for Ekso Bionics. How were Ekso Bionics' earnings last quarter? Ekso Bionics Holdings Inc (NASDAQ:EKSO) announced its quarterly earnings data on Thursday, July, 30th. The company reported ($1.88) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by $1.32. The firm had revenue of $2.26 million for the quarter, compared to analysts' expectations of $1.85 million. Ekso Bionics had a negative return on equity of 275.25% and a negative net margin of 156.16%. View Ekso Bionics' earnings history. When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work? Ekso Bionics shares reverse split before market open on Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split. What price target have analysts set for EKSO? 3 brokerages have issued twelve-month price objectives for Ekso Bionics' shares. Their forecasts range from $8.00 to $12.00. On average, they expect Ekso Bionics' stock price to reach $9.67 in the next year. This suggests a possible upside of 90.7% from the stock's current price. View analysts' price targets for Ekso Bionics. Are investors shorting Ekso Bionics? Ekso Bionics saw a decline in short interest during the month of August. As of August 31st, there was short interest totaling 240,100 shares, a decline of 24.8% from the August 15th total of 319,100 shares. Based on an average daily volume of 2,960,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 3.3% of the shares of the company are sold short. View Ekso Bionics' Short Interest. Who are some of Ekso Bionics' key competitors? Some companies that are related to Ekso Bionics include Nordson (NDSN), Altra Industrial Motion (AIMC), Taylor Devices (TAYD), International Baler (IBAL) and China Energy Recovery (CGYV). View all competitors. What other stocks do shareholders of Ekso Bionics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Ekso Bionics investors own include OrganiGram (OGI), Gran Tierra Energy (GTE), Cannabics Pharmaceuticals (CNBX), KushCo (KSHB), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Pennsylvania R.E.I.T. (PEI), AEterna Zentaris (AEZS), BioNano Genomics (BNGO) and ADMA Biologics (ADMA). Who are Ekso Bionics' key executives? Ekso Bionics' management team includes the following people: Mr. Steven A. Sherman, Exec. Chairman (Age 73)Mr. Jack Peurach, Pres, CEO & Director (Age 53)Mr. John F. Glenn, CFO & Sec. (Age 57)Mr. William Shaw, Chief Commercial Officer (Age 45)Ms. Foon Lim Chwee, Pres of APAC What is Ekso Bionics' stock symbol? Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO." Who are Ekso Bionics' major shareholders? Ekso Bionics' stock is owned by a number of institutional and retail investors. Top institutional investors include Atom Investors LP (0.91%), WINTON GROUP Ltd (0.24%), Bank of Montreal Can (0.23%) and Strategic Wealth Designers (0.18%). View institutional ownership trends for Ekso Bionics. Which institutional investors are buying Ekso Bionics stock? EKSO stock was purchased by a variety of institutional investors in the last quarter, including Atom Investors LP, Bank of Montreal Can, Strategic Wealth Designers, and WINTON GROUP Ltd. View insider buying and selling activity for Ekso Bionics. How do I buy shares of Ekso Bionics? Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Ekso Bionics' stock price today? One share of EKSO stock can currently be purchased for approximately $5.07. How big of a company is Ekso Bionics? Ekso Bionics has a market capitalization of $41.93 million and generates $13.92 million in revenue each year. The company earns $-12,130,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis. Ekso Bionics employs 77 workers across the globe. What is Ekso Bionics' official website? The official website for Ekso Bionics is www.eksobionics.com. How can I contact Ekso Bionics? Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected] This page was last updated on 9/18/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
